Sunday, September 13, 2020

AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases (Leah Rosenbaum/Forbes)

Leah Rosenbaum / Forbes:
AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases  —  Startups that want to leverage artificial intelligence in drug discovery are a dime a dozen in today's biotech landscape.



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Chinese video game giant NetEase reports Q4 revenue up 3% YoY to ~$4B and net profit down 29% to ~$903M, below ~$1.2B est., as it pushes self-developed games (Sherry Qin/Wall Street Journal)

Sherry Qin / Wall Street Journal : Chinese video game giant NetEase reports Q4 revenue up 3% YoY to ~$4B and net profit down 29% to ~$903...